These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16137634)

  • 21. The use of cell-penetrating peptides for drug delivery.
    Temsamani J; Vidal P
    Drug Discov Today; 2004 Dec; 9(23):1012-9. PubMed ID: 15574317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cellular uptake using 22 CPPs in 4 different cell lines.
    Mueller J; Kretzschmar I; Volkmer R; Boisguerin P
    Bioconjug Chem; 2008 Dec; 19(12):2363-74. PubMed ID: 19053306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell entry of cell penetrating peptides: tales of tails wagging dogs.
    Jones AT; Sayers EJ
    J Control Release; 2012 Jul; 161(2):582-91. PubMed ID: 22516088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of cell penetrating peptides (CPPs).
    Kerkis A; Hayashi MA; Yamane T; Kerkis I
    IUBMB Life; 2006 Jan; 58(1):7-13. PubMed ID: 16540427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
    Manceur A; Wu A; Audet J
    Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell transduction pathways of transportans.
    Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
    Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.
    Ziegler A
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):580-97. PubMed ID: 18045730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
    Mäe M; Langel U
    Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new rapid cell-penetrating peptide based strategy to produce bacterial ghosts for plasmid delivery.
    Palm-Apergi C; Hällbrink M
    J Control Release; 2008 Nov; 132(1):49-54. PubMed ID: 18786580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction of cell-penetrating peptides with lipid model systems and subsequent lipid reorganization: thermodynamic and structural characterization.
    Alves ID; Correia I; Jiao CY; Sachon E; Sagan S; Lavielle S; Tollin G; Chassaing G
    J Pept Sci; 2009 Mar; 15(3):200-9. PubMed ID: 18985709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free uptake of cell-penetrating peptides by fission yeast.
    Parenteau J; Klinck R; Good L; Langel U; Wellinger RJ; Elela SA
    FEBS Lett; 2005 Aug; 579(21):4873-8. PubMed ID: 16111683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential membrane perturbation caused by the cell penetrating peptide Tp10 depending on attached cargo.
    Bárány-Wallje E; Gaur J; Lundberg P; Langel U; Gräslund A
    FEBS Lett; 2007 May; 581(13):2389-93. PubMed ID: 17485081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular uptake of cell-penetrating peptides pVEC and transportan in plants.
    Chugh A; Eudes F
    J Pept Sci; 2008 Apr; 14(4):477-81. PubMed ID: 17985395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB; Pereira MP; Kelley SO
    Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.
    Lindgren M; Rosenthal-Aizman K; Saar K; Eiríksdóttir E; Jiang Y; Sassian M; Ostlund P; Hällbrink M; Langel U
    Biochem Pharmacol; 2006 Feb; 71(4):416-25. PubMed ID: 16376307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues.
    Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY
    Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the interaction, positioning, structure induction and membrane perturbation of cell-penetrating peptides and non-translocating variants with phospholipid vesicles.
    Magzoub M; Eriksson LE; Gräslund A
    Biophys Chem; 2003 Mar; 103(3):271-88. PubMed ID: 12727289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides.
    Fischer R; Fotin-Mleczek M; Hufnagel H; Brock R
    Chembiochem; 2005 Dec; 6(12):2126-42. PubMed ID: 16254940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-metabolic membrane tubulation and permeability induced by bioactive peptides.
    Lamazière A; Burlina F; Wolf C; Chassaing G; Trugnan G; Ayala-Sanmartin J
    PLoS One; 2007 Feb; 2(2):e201. PubMed ID: 17299584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
    Wolf Y; Pritz S; Abes S; Bienert M; Lebleu B; Oehlke J
    Biochemistry; 2006 Dec; 45(50):14944-54. PubMed ID: 17154532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.